The study aims to evaluate the pharmacokinetics properties of the therapy in up to ten adult subjects with genetically confirmed DMD. Credit: Volha_R/Shutterstock. Satellos Bioscience has dosed the ...
Tissue Penetration: Consistent with the recently updated trial protocol, tissue Css levels were evaluated in addition to plasma Css levels. The 80 mg/day dose, in both treatment arms, achieved tissue ...
with advances in pharmacology offering more targeted and effective options. Antidepressants, anti-anxiety medications, mood stabilizers, and antipsychotics are carefully prescribed based on the ...